Rheumatoid arthritis is a systemic autoimmune disease with chronic inflammation, cartilage and bone destruction. The existing research has found that the development of the disease is closely related to the IL-23/IL-17 signaling pathway. In this paper, the effects of IL-23, IL-17 and IL-23/IL-17 inflammatory axis on the pathogenesis of rheumatoid arthritis and the treatment of drugs related to the axis are reviewed, which provide a new wa...